Effect of low-level HCV viraemia at week 24 on HCV treatment response in genotype 1 patients.
Baleriola C, Rawlinson WD, Dore GJ, Chaverot S, Stelzer-Braid S, Yoshihara M, Crawford D, Sievert W, McCaughan G, Weltman M, Cheng W, Rizkalla B, Dubois D, Thommes J, Roberts S.
Baleriola C, et al. Among authors: chaverot s.
Antivir Ther. 2011;16(2):173-80. doi: 10.3851/IMP1731.
Antivir Ther. 2011.
PMID: 21447866
Clinical Trial.